An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the knee

Osteoarthritis and Cartilage

Volumn 14, Issue 9, 2006, Pages 859-866

  Strand, V ^a   Conaghan, P G ^b   Lohmander, L S ^c   Koutsoukos, A D ^d   Hurley, F L ^e   Bird, H ^b   Brooks, P ^f   Day, R ^g   Puhl, W ^h   Band, P A ⁱ  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c LUND UNIVERSITY   (Sweden)

^d IQVIA   (United States)

^e RRD International   (United States)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h UNIVERSITY OF ULM   (Germany)

ⁱ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hyaluronan; Hyaluronate; Hyaluronic; Intra articular; Knee; Meta analysis; Osteoarthritis; Viscosupplementation

Indexed keywords

DICLOFENAC; HYALURONIC ACID; PLACEBO; SODIUM CHLORIDE;

ANALYSIS OF COVARIANCE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COUGHING; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; HAY FEVER; HUMAN; INJECTION; INJECTION SITE PAIN; INJECTION SITE REACTION; KNEE OSTEOARTHRITIS; META ANALYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZATION; SCORING SYSTEM; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; UNITED STATES;

AGED; DOUBLE-BLIND METHOD; DRUG AND NARCOTIC CONTROL; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 33746507275     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2006.02.012     Document Type: Article

References (32)

1. Altman D. Hyaluronate therapy in osteoarthritis - introduction. Semin Arthritis Rheum 30 (2000) 1
2. Brandt K.D., Smith G.N., and Simon L.S. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis. Arthritis Rheum 43 (2000) 1192-1203
3. Felson D.T. Hyaluronate sodium injections for osteoarthritis: hope, hype, and hard truths. Arch Intern Med 162 (2002) 245-247
4. Lo G., LaValley M., McAlindon T., and Felson D. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 290 (2003) 3115-3127
5. Wang C.T., Lin J., Chang C.J., Lin Y.T., and Hou S.M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86-A (2004) 538-545
6. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., and Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2 (2005) CD005321
7. Goldberg V.M., and Coutts R.D. Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment. Clin Orthop 419 (2004) 130-137
8. Hamburger M.I., Lakhanpal S., Mooar P.A., and Oster D. Intra-articular hyaluronans: a review of product-specific safety profiles. Semin Arthritis Rheum 32 (2003) 296-309
9. ® Rockville, MD (January 24, 2001). http://www.fda.gov/cdrh/pdf/P980044b.pdf
10. Puhl W., Bernau A., Greiling H., Kopcke W., Pforringer W., Steck K.J., et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multi-center double-blind study. Osteoarthritis Cartilage 1 (1993) 97-103
11. Day R., Brooks P., Conaghan P.G., and Petersen M. A double-blind, randomized, multi-center, parallel group study of the effectiveness and tolerance of intra-articular hyaluronan in osteoarthritis of the knee. J Rheumatol 31 (2004) 775-782
12. Lohmander L.S., Dalen N., Englund G., Hamalainen M., Jensen E.M., Karlsson K., et al. Sodium hyaluronan solution injections in the treatment of osteoarthritis of the knee: a randomized double blind placebo controlled multicenter trial. Ann Rheum Dis 55 (1996) 424-431
13. Altman R., Brandt K., Hochberg M., and Moskowitz R. For the task force: design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Osteoarthritis Cartilage 4 (1996) 217-243
14. European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit, Committee for Proprietary Medicinal Products. Points to consider on clinical investigation of medicinal products used in the treatment of osteoarthritis. Draft 8, July 16, 1998.
15. Strand V., and Kelman A. Outcome measures in randomized controlled trials in osteoarthritis. Curr Rheumatol Rep 6 (2004) 20-30
16. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Devices and Radiologic Health. Guidance for industry: clinical development programs for drugs, devices and biological products intended for the treatment of osteoarthritis. Draft, July 1999.
17. Laird N.M., and Ware J.H. Random-effects models for longitudinal data. Biometrics 38 (1982) 963-974
18. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 1 (1996) 1-12
19. The European Agency for the Evaluation of Medicinal Products. Points to consider on application with 1. Meta-analyses; 2. One Pivotal Study. http://www.emea.eu.int/pdfs/human/ewp/233099.en.pdf
20. Adams M.E., Atkinson M.H., Lussier A.J., Schulz J.I., Siminovitch K.A., Wade J.P., et al. The role of viscosupplementation with hylan G-F 20 (Synvisc™) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAID) and NSAID alone. Osteoarthritis Cartilage 3 (1995) 213-226
21. Huskisson E.C., and Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 38 (1999) 602-607
22. Altman R.D., Moskowitz R., and the Hyalgan study group. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol 25 (1998) 2203-2212
23. Jubb R.W., Beinat L., Dacre J., and Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 KDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract 57 (2003) 467-474
24. Felson D.T. The verdict favors nonsteroidal anti-inflammatory drugs for treatment of osteoarthritis and a plea for more evidence on other treatments. Arthritis Rheum 44 7 (2001) 1477-1480
25. Miler J.H., White J., and Norton T.H. The value of intra-articular injections in osteoarthritis of the knee. J Bone Joint Surg Br 40-B (1958) 636-643
26. Schumacher Jr. H.R. Aspiration and injection therapies for joints. Arthritis Rheum 49 3 (2003) 413-420
27. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., and Wells G. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2 (2005) CD005328
28. Wobig M., Dickhut A., Maier R., and Vetter G. Viscosupplementation with Hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20 (1998) 410-423
29. Dougados M., Nguyen M., Listrat V., and Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1 (1993) 97-103
30. Brandt K.D., Black J.A., Michalski J.P., Moreland L.W., Caldwell J.R., Lavin P.T., et al. Efficacy and safety of intra-articular sodium-hyaluronate in knee osteoarthritis. Clin Orthop 385 (2001) 130-143
31. Karlsson J., Sjogren S., and Lohmander L.S. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 41 (2002) 1240-1248
32. Petrella R.J., DiSilvestro M.D., and Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee. Arch Intern Med 162 (2002) 292-298